submitter_id.samples	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	batch_number	bcr	bcr_followup_barcode	bcr_followup_uuid	submitter_id	breast_cancer_surgery_margin_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator	day_of_dcc_upload	day_of_form_completion	days_to_additional_surgery_metastatic_procedure	days_to_initial_pathologic_diagnosis	days_to_new_tumor_event_after_initial_treatment	distant_metastasis_present_ind2	file_uuid	followup_case_report_form_submission_reason	her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	histological_type_other	history_of_neoadjuvant_treatment	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	lost_follow_up	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	metastatic_breast_carcinoma_progesterone_receptor_status	metastatic_site_at_diagnosis_other	month_of_dcc_upload	month_of_form_completion	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	other_dx	pathologic_M	pathologic_N	pathologic_T	patient_id	person_neoplasm_cancer_status	pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	radiation_therapy	surgical_procedure_purpose_other_text	system_version	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	withdrawn	year_of_dcc_upload	year_of_form_completion	year_of_initial_pathologic_diagnosis	days_to_index	dbgap_registration_code	disease_code	pathology_report_file_name	program	project_code	vial_number	age_at_index.demographic	days_to_birth.demographic	days_to_death.demographic	ethnicity.demographic	gender.demographic	race.demographic	vital_status.demographic	year_of_birth.demographic	year_of_death.demographic	age_at_diagnosis.diagnoses	classification_of_tumor.diagnoses	days_to_diagnosis.diagnoses	days_to_last_follow_up.diagnoses	icd_10_code.diagnoses	last_known_disease_status.diagnoses	morphology.diagnoses	primary_diagnosis.diagnoses	prior_malignancy.diagnoses	prior_treatment.diagnoses	progression_or_recurrence.diagnoses	site_of_resection_or_biopsy.diagnoses	synchronous_malignancy.diagnoses	tissue_or_organ_of_origin.diagnoses	tumor_grade.diagnoses	tumor_stage.diagnoses	year_of_diagnosis.diagnoses	disease_type	alcohol_history.exposures	primary_site	name.project	project_id.project	releasable.project	bcr_id.tissue_source_site	code.tissue_source_site	name.tissue_source_site	project.tissue_source_site	days_to_collection.samples	days_to_sample_procurement.samples	initial_weight.samples	is_ffpe.samples	oct_embedded.samples	preservation_method.samples	sample_type.samples	sample_type_id.samples	state.samples	tissue_type.samples
Patient1					63	Sentinel lymph node biopsy plus axillary dissection		56.91.0	Nationwide Children's Hospital	TCGA-A2-A0CY-F13731	AE7B55F3-F2F1-4FA6-9921-07C9E99F7EEB	TCGA-A2-A0CY					Simple Mastectomy		YES	22	9		0			CB4EDFB6-1C3C-43AD-BAAD-0A3D8DC81EA8	Scheduled Follow-up Submission				No	YES		Core needle biopsy		22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																						12	6				NO	1	0	No	M0	N1	T2	A0CY	TUMOR FREE		YES		NO		6th	NO	YES	A2	FALSE	2016	2011	2006	0		BRCA	TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21.pdf		TCGA	A	63	-23229		not hispanic or latino	female	white	Alive	1943		23229	not reported	0	1673	C50.9	not reported	8500/3	"Infiltrating duct carcinoma, NOS"	no	No	not reported	"Breast, NOS"	No	"Breast, NOS"	not reported	stage iib	2006	Ductal and Lobular Neoplasms	Not Reported	Breast	Breast Invasive Carcinoma	TCGA-BRCA	FALSE	NCH	A2	Walter Reed	Breast invasive carcinoma	1274		220	FALSE	TRUE		Primary Tumor	01	released	Not Reported